Do you want to volunteer for Clinical Trials? Register now

Important Information

By taking part in a Clinical Study you can help in the development of new medicines that will save lives, you may also be reimbursed for giving up your time and any expenses that you may incur taking part in any medical trial.

Important Information

When an investigator or company contact you to discuss taking part in any clinical study please remember that your safety is paramount and you should ensure that you are aware of all the information about the study before taking part and that you ask questions of the doctors and medical professionals involved. The Clinical Trials industry is heavily regulated and the standards of care that you will receive from reputable organizations will be very high. They are trained and willing to answer any questions that you have.

Because your safety is their primary concern, you should stay under their care throughout the study which may sometimes include overnight stays.

More information

Useful Medical Trial information

News

Cannabis intoxication may be stopped with anti-obesity drug

Intoxication with so-called legal highs may be fatal. But new research may have found the antidote in a slimming drug that blocks cannabinoid receptors. Powered by WPeMatico

more >

Heart failure could be treated using umbilical cord stem cells

In the first study of its kind, researchers find that stem cells derived from the umbilical cord can be used to treat heart failure. Powered by WPeMatico

more >

Poliovirus kills off cancer cells, stops tumor regrowth

A modified poliovirus appears to trigger the body’s anti-tumor immunity. The new study showed promising results in human breast cancer cells and mice. Powered by WPeMatico

more >

Drug resistance: WHO report ‘serious lack of new antibiotics’

A new report from the WHO reveals that the current scope of new antibiotic development is far from what is needed to tackle drug resistance. Powered by WPeMatico

more >

Alexion restructures, cuts workforce 20%

Alexion Pharmaceuticals announced an operational plan to re-align the global organization with its refocused corporate strategy. The plan is expected to deliver approximately $270 million in GAAP and approximately $250 million in non-GAAP pre-tax savings annually by 2019. The restructuring will reduce the company‚Äôs global workforce by approximately 20%. The resulting savings will allow Alexion […]

more >

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of institutional and private investors. As part of the transaction, ProQR has granted an exclusive license to Amylon to develop therapeutics for beta amyloid related disorders. Amylon […]

more >